Christopher F. O' Brien, MD
- 2Articles
- 19.9KReads1
- 2017–2018Active
- 10Collaborators
- 81Citations2
About
Christopher F. O'Brien, MD, has published research focused on the treatment of tardive dyskinesia, specifically examining the effects of valbenazine. His work includes analyses from the KINECT 3 study and its extension, contributing to the clinical understanding of this neurological condition. O'Brien has collaborated with co-authors such as Christoph U. Correll and Grace S. Liang in articles published between 2017 and 2018 in Psychiatrist.com.
Publications
Valbenazine for Tardive Dyskinesia: Results From the KINECT 3 Study
December 18, 2018
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
